Moreover, high expression of HSP110 has been found to be associated with worse prognosis of non-small cell lung cancer [74], and head and neck squamous carcinoma [75]; HSP110 overexpression has been described in hepatocellular carcinoma [76], and in malignant melanoma with relation to invasiveness [77]. Here, HSPH1 is linked to hepatocellular carcinoma.